These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 4991253)

  • 1. Rationale for the use of L-dopa in the torsion dystonias.
    Barbeau A
    Neurology; 1970 Nov; 20(11):96-102. PubMed ID: 4991253
    [No Abstract]   [Full Text] [Related]  

  • 2. [L-DOPA therapy of deforming muscular dystonia in children].
    Mel'nichuk PV; Sosnovskaia LS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(10):1495-8. PubMed ID: 4775332
    [No Abstract]   [Full Text] [Related]  

  • 3. The treatment of dystonia with L-dopa and haloperidol.
    Mandell S
    Neurology; 1970 Nov; 20(11):103-6. PubMed ID: 5529471
    [No Abstract]   [Full Text] [Related]  

  • 4. The pharmacology of extrapyramidal movement disorders.
    Klawans HL
    Monogr Neural Sci; 1973; 2():1-136. PubMed ID: 4271860
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug-induced movement disorders.
    North RR
    Postgrad Med; 1971 Sep; 50(3):180-5. PubMed ID: 5092993
    [No Abstract]   [Full Text] [Related]  

  • 6. Torsion dystonia and spasmodic torticollis--results of treatment with L-dopa.
    Barrett RE; Yahr MD; Duvoisin RC
    Neurology; 1970 Nov; 20(11):107-13. PubMed ID: 5529472
    [No Abstract]   [Full Text] [Related]  

  • 7. [Disulfiram and L-dopa in patients with Parkinson's syndrome and in torsion dystonia].
    Serrano PA; Irigoyen M
    Prensa Med Mex; 1972; 37(7):246-50. PubMed ID: 4646433
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of manganese in dystonia.
    Barbeau A; Inoué N; Cloutier T
    Adv Neurol; 1976; 14():339-52. PubMed ID: 821321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of L-dopa induced dyskinesias in 51 patients with Parkinsonism.
    Mones RJ; Elizan TS; Siegel GJ
    J Neurol Neurosurg Psychiatry; 1971 Dec; 34(6):668-73. PubMed ID: 5158780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-Dopa and Parkinsonism.
    Calne DB; Sandler M
    Nature; 1970 Apr; 226(5240):21-4. PubMed ID: 4907560
    [No Abstract]   [Full Text] [Related]  

  • 11. [The therapeutic effect of L-dopa].
    Groneberg P; Struppler A
    Naturwissenschaften; 1972 Nov; 59(11):492-6. PubMed ID: 4657650
    [No Abstract]   [Full Text] [Related]  

  • 12. [Long-term treatment with L-DOPA in a case of torsion dystonia (authors transl)].
    Winkelmann W
    J Neurol; 1975; 208(4):319-23. PubMed ID: 50417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Abnormal movements observed during treatment of Parkinson's disease with L-dopa].
    Sigwald J; Raymondeaud C
    Rev Neurol (Paris); 1970 Feb; 122(2):103-12. PubMed ID: 4397165
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experience with L-DOPA treatment of children with dystonia musculorum deformans and dystonic hyperkineses in infantile cerebral palsy].
    Bondarenko ES; Malyshev IuI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(10):1471-5. PubMed ID: 4072505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary remarks on the L-dopa therapy of dystonia.
    Coleman M
    Neurology; 1970 Nov; 20(11):114-21. PubMed ID: 5529473
    [No Abstract]   [Full Text] [Related]  

  • 16. Psychiatric side effects of levodopa in man.
    Goodwin FK
    JAMA; 1971 Dec; 218(13):1915-20. PubMed ID: 5000569
    [No Abstract]   [Full Text] [Related]  

  • 17. Levodopa in dystonia musculorum deformans.
    Rajput AH
    Lancet; 1973 Feb; 1(7800):432. PubMed ID: 4119748
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of Parkinson's disease with L-dopa].
    Guglielmi L; Vecchi L
    Clin Ter; 1970 May; 53(3):259-69. PubMed ID: 4917328
    [No Abstract]   [Full Text] [Related]  

  • 19. Pathophysiology of drug-induced dyskinesias.
    Korczyn AD
    Neuropharmacology; 1972 Sep; 11(5):601-7. PubMed ID: 4275111
    [No Abstract]   [Full Text] [Related]  

  • 20. The neuropharmacology of abnormal involuntary movement disorders (the dyskinesias).
    Marsden CD
    Mod Trends Neurol; 1975; 6():141-66. PubMed ID: 127927
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.